Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 248

Similar articles for PubMed (Select 14764937)

1.

Infection by Shiga toxin-producing Escherichia coli: an overview.

Karmali MA.

Mol Biotechnol. 2004 Feb;26(2):117-22. Review.

PMID:
14764937
2.

Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.

Wickham ME, Lupp C, Mascarenhas M, Vazquez A, Coombes BK, Brown NF, Coburn BA, Deng W, Puente JL, Karmali MA, Finlay BB.

J Infect Dis. 2006 Sep 15;194(6):819-27. Epub 2006 Aug 11.

3.

Shiga toxin-producing Escherichia coli: an overview.

Gyles CL.

J Anim Sci. 2007 Mar;85(13 Suppl):E45-62. Epub 2006 Nov 3. Review.

4.

Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157 in Austria.

Orth D, Grif K, Zimmerhackl LB, Würzner R.

Wien Klin Wochenschr. 2009;121(3-4):108-12. doi: 10.1007/s00508-008-1133-z.

PMID:
19280135
5.

Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains.

Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA.

Appl Environ Microbiol. 2008 Apr;74(7):2153-60. doi: 10.1128/AEM.02566-07. Epub 2008 Feb 1.

6.

Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.

Rivas M, Miliwebsky E, Chinen I, Roldán CD, Balbi L, García B, Fiorilli G, Sosa-Estani S, Kincaid J, Rangel J, Griffin PM; Case-Control Study Group.

Foodborne Pathog Dis. 2006 Spring;3(1):88-96.

PMID:
16602984
7.

The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.

Johnson KE, Thorpe CM, Sears CL.

Clin Infect Dis. 2006 Dec 15;43(12):1587-95. Epub 2006 Nov 9.

8.

[The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].

Rivas M, Miliwebsky E, Chinen I, Deza N, Leotta GA.

Medicina (B Aires). 2006;66 Suppl 3:27-32. Spanish.

PMID:
17354474
9.

Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections.

Karch H, Bielaszewska M, Bitzan M, Schmidt H.

Diagn Microbiol Infect Dis. 1999 Jul;34(3):229-43. Review.

PMID:
10403103
10.

Enterohaemorrhagic Escherichia coli in human medicine.

Karch H, Tarr PI, Bielaszewska M.

Int J Med Microbiol. 2005 Oct;295(6-7):405-18. Review.

PMID:
16238016
11.

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Tarr PI, Gordon CA, Chandler WL.

Lancet. 2005 Mar 19-25;365(9464):1073-86. Review.

PMID:
15781103
12.

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.

Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.

Pediatrics. 2005 Jun;115(6):e673-80.

PMID:
15930195
13.

[Role of the Shiga toxin in the hemolytic uremic syndrome].

Creydt VP, Nuñez P, Boccoli J, Silberstein C, Zotta E, Goldstein J, Ibarra C.

Medicina (B Aires). 2006;66 Suppl 3:11-5. Review. Spanish.

PMID:
17354471
14.

Prevalence and pathogenicity of Shiga toxin-producing Escherichia coli in beef cattle and their products.

Hussein HS.

J Anim Sci. 2007 Mar;85(13 Suppl):E63-72. Epub 2006 Oct 23. Review.

15.

[New knowledge of the molecular biology of enterohemorrhagic Escherichia coli (EHEC) O157].

Karch H, Köhler B.

Gesundheitswesen. 1999 Oct;61 Spec No 1:S46-51. German.

PMID:
10593045
16.

Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.

Kim YB, Okuda J, Matsumoto C, Morigaki T, Asai N, Watanabe H, Nishibuchi M.

FEMS Microbiol Lett. 1998 Sep 1;166(1):43-8.

17.

The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome.

Cleary TG.

Semin Pediatr Infect Dis. 2004 Oct;15(4):260-5. Review.

PMID:
15494950
18.

Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.

Müthing J, Schweppe CH, Karch H, Friedrich AW.

Thromb Haemost. 2009 Feb;101(2):252-64. Review.

PMID:
19190807
19.
20.

Vero cytotoxin binding to polymorphonuclear leukocytes among households with children with hemolytic uremic syndrome.

te Loo DM, Heuvelink AE, de Boer E, Nauta J, van der Walle J, Schröder C, van Hinsbergh VW, Chart H, van de Kar NC, van den Heuvel LP.

J Infect Dis. 2001 Aug 15;184(4):446-50. Epub 2001 Jul 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk